Iron deficiency is associated with reduced levels of inflammation and haemolysis in patients with HbSS and HbSC and reduced clinical admissions in those with HbSC
British Journal of Haematology · 2026
DOI: 10.1111/bjh.70262 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2026. Verfasst von Simone Villaboni und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematological Medicine, King's College Hospital, London, UK. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Hemolysis, Inflammation, Anemia, Iron-Deficiency. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Evidence suggests that iron deficiency may reduce sickle cell disease (SCD) complications by decreasing sickle haemoglobin polymerization through reduced red cell haemoglobin concentration. The aim is to investigate the effects of iron deficiency in SCD patients. We reviewed clinical and laboratory data from 512 patients (408 HbSS, 104 HbSC) at King's College Hospital (2008–2020). Outpatient data were collected from patients with no blood transfusions or hydroxyurea (hydroxycarbamide) use in the prior 90 days. Patients were categorized as hypoferritinaemic (800 μg/L) and analysed for laboratory markers and clinical complications. In HbSC patients, hypoferritinaemia was associated with significantly fewer hospital admissions and inpatient days per year compared to normoferritinaemia. Although this was not seen in HbSS patients, hypoferritinaemia correlates with lower haemolysis and inflammation markers, with no differences in total haemoglobin or erythropoietin in both groups. In HbSS patients, haemoglobin F was significantly lower in hypoferritinaemic compared to normoferritinaemic patients. Iron deficiency may reduce inflammation and haemolysis in both HbSS and HbSC, with clinical benefits demonstrable in HbSC. Low ferritin levels were not associated with increased anaemia, suggesting improved red cell survival. Iron‐restricted erythropoiesis may benefit SCD patients in certain circumstances.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Haematological Medicine, King's College Hospital, London, UK.
- Red Cell Haematology Laboratory, Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
- Department of Engineering for Innovative Medicine, University of Verona, Verona, Italy.
ORCID-Profile: Simone Villaboni, John N Brewin
Zitieren
APA
Villaboni, S., Stuart-Smith, S., De Kreuk, A., Rees, D. C., & Brewin, J. N. (2026). Iron deficiency is associated with reduced levels of inflammation and haemolysis in patients with HbSS and HbSC and reduced clinical admissions in those with HbSC. British Journal of Haematology. https://doi.org/10.1111/bjh.70262
Vancouver
Villaboni S, Stuart-Smith S, De Kreuk A, Rees DC, Brewin JN. Iron deficiency is associated with reduced levels of inflammation and haemolysis in patients with HbSS and HbSC and reduced clinical admissions in those with HbSC. British Journal of Haematology. 2026. doi:10.1111/bjh.70262
BibTeX
@article{Villaboni2026,
author = {Villaboni, Simone and Stuart-Smith, Sara and De Kreuk, Arne and Rees, David C and Brewin, John N},
title = {Iron deficiency is associated with reduced levels of inflammation and haemolysis in patients with HbSS and HbSC and reduced clinical admissions in those with HbSC},
journal = {British Journal of Haematology},
year = {2026},
doi = {10.1111/bjh.70262}
}
EUVIMED